Clinical Trial

Duodenal pulsENDO as an Early Treatment for Type 2 DM

Study acronym: DREAM-1
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is designed to evaluate the efficacy and safety of endoscopic duodenal re-cellularization therapy using pulsed electric field in individuals with in patients with a recent diagnosis of type 2 diabetes mellitus (T2DM).
Protocol Amendment History 2 changes
notable Primary completion pushed: 2030-08-30 -> 2031-02-28 2026-06-25
minor Completion pushed: 2032-02-28 -> 2032-08-30 2026-06-25
Trial Details
NCT Number NCT07376486
Lead Sponsor Chinese University of Hong Kong
Conditions Diabete Mellitus, T2 Diabetes and Fatty Liver Disease (Non-alcoholic Origin)
Enrollment 40 participants
Start Date 2026-09-01
Primary Completion 2031-02-28 (estimated)
Study Completion 2032-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-24